Cereno Scientific Investor Relations Material
Latest events
Study Update
Cereno Scientific
Q2 2025
27 Aug, 2025
Q1 2025
22 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Cereno Scientific
Access all reports
Cereno Scientific is a biotechnology company developing epigenetic therapies for cardiovascular and rare diseases. The company focuses on compounds that modulate endogenous defense mechanisms, with applications in thrombosis and inflammation. It operates in preclinical and clinical research stages. The company is headquartered in Gothenburg, Sweden, and its shares are listed on the STO.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CRNO
Country
🇸🇪 Sweden